These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 10515857)

  • 1. Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera.
    Moliterno AR; Spivak JL
    Blood; 1999 Oct; 94(8):2555-61. PubMed ID: 10515857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet protein synthesis, regulation, and post-translational modifications: mechanics and function.
    Soslau G
    Crit Rev Biochem Mol Biol; 2023 Dec; 58(2-6):99-117. PubMed ID: 37347996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.
    Besancenot R; Roos-Weil D; Tonetti C; Abdelouahab H; Lacout C; Pasquier F; Willekens C; Rameau P; Lecluse Y; Micol JB; Constantinescu SN; Vainchenker W; Solary E; Giraudier S
    Blood; 2014 Sep; 124(13):2104-15. PubMed ID: 25143485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.
    Moliterno AR; Hankins WD; Spivak JL
    N Engl J Med; 1998 Feb; 338(9):572-80. PubMed ID: 9475764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia.
    Karantanos T; Teodorescu P; Perkins B; Christodoulou I; Esteb C; Varadhan R; Helmenstine E; Rajkhowa T; Paun BC; Bonifant C; Dalton WB; Gondek LP; Moliterno AR; Levis MJ; Ghiaur G; Jones RJ
    Sci Adv; 2022 Feb; 8(7):eabl8952. PubMed ID: 35179961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN.
    Spivak JL; Moliterno AR
    Front Oncol; 2021; 11():641613. PubMed ID: 33777803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera.
    Spivak JL; Merchant A; Williams DM; Rogers O; Zhao W; Duffield A; Resar LS; Moliterno AR; Zhao ZJ
    PLoS One; 2020; 15(6):e0232801. PubMed ID: 32479500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Roles of Glycans in Hematological Malignancies.
    Pang X; Li H; Guan F; Li X
    Front Oncol; 2018; 8():364. PubMed ID: 30237983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel signalling screen demonstrates that CALR mutations activate essential MAPK signalling and facilitate megakaryocyte differentiation.
    Kollmann K; Warsch W; Gonzalez-Arias C; Nice FL; Avezov E; Milburn J; Li J; Dimitropoulou D; Biddie S; Wang M; Poynton E; Colzani M; Tijssen MR; Anand S; McDermott U; Huntly B; Green T
    Leukemia; 2017 Apr; 31(4):934-944. PubMed ID: 27740635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells.
    Wang X; Haylock D; Hu CS; Kowalczyk W; Jiang T; Qiu J; Mosoyan G; He W; Marshall N; Mascarenhas J; Tarasova A; Brody J; Winkler D; Hoffman R
    Blood; 2016 Jun; 127(26):3398-409. PubMed ID: 27114459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm.
    Fleischman AG
    Mediators Inflamm; 2015; 2015():606819. PubMed ID: 26538830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells.
    Lu M; Xia L; Liu YC; Hochman T; Bizzari L; Aruch D; Lew J; Weinberg R; Goldberg JD; Hoffman R
    Blood; 2015 Aug; 126(8):972-82. PubMed ID: 26022238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mpl traffics to the cell surface through conventional and unconventional routes.
    Cleyrat C; Darehshouri A; Steinkamp MP; Vilaine M; Boassa D; Ellisman MH; Hermouet S; Wilson BS
    Traffic; 2014 Sep; 15(9):961-82. PubMed ID: 24931576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular domain N-glycosylation controls human thrombopoietin receptor cell surface levels.
    Albu RI; Constantinescu SN
    Front Endocrinol (Lausanne); 2011; 2():71. PubMed ID: 22649382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK2 V617F and the evolving paradigm of polycythemia vera.
    Means RT
    Korean J Hematol; 2010 Jun; 45(2):90-4. PubMed ID: 21120186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound heterozygous c-Mpl mutations in a child with congenital amegakaryocytic thrombocytopenia: functional characterization and a review of the literature.
    Fox NE; Chen R; Hitchcock I; Keates-Baleeiro J; Frangoul H; Geddis AE
    Exp Hematol; 2009 Apr; 37(4):495-503. PubMed ID: 19302922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-independent thrombopoietin mutant receptor requires cell surface localization for endogenous activity.
    Marty C; Chaligné R; Lacout C; Constantinescu SN; Vainchenker W; Villeval JL
    J Biol Chem; 2009 May; 284(18):11781-91. PubMed ID: 19261614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation.
    Hitchcock IS; Chen MM; King JR; Kaushansky K
    Blood; 2008 Sep; 112(6):2222-31. PubMed ID: 18487512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the bcr-abl negative chronic myeloproliferative diseases.
    Bennett M; Stroncek DF
    J Transl Med; 2006 Oct; 4():41. PubMed ID: 17032464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression.
    Moliterno AR; Williams DM; Rogers O; Spivak JL
    Blood; 2006 Dec; 108(12):3913-5. PubMed ID: 16912229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.